AgEagle Aerial Systems (UAVS) 10-K 13 Apr 20 2019 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Apr. 13, 2020	Jun. 30, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	AgEagle Aerial Systems Inc.
Entity Central Index Key	0000008504
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Interactive Data Current	Yes
Entity File Number	001-36492
Entity Incorporation, State Country Code	NV
Entity Public Float			$ 4,732,318
Entity Common Stock, Shares Outstanding		16,774,394

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash	$ 717,997	$ 2,601,730
Accounts receivable	65,833	93
Inventories, net	221,167	149,482
Prepaid and other current assets	124,163	80,370
Total current assets	1,129,160	2,831,675
Property and equipment, net	37,776	28,374
Intangible assets, net	520,573	677,118
Goodwill	3,108,000	3,270,984
Total assets	4,795,509	6,808,151
CURRENT LIABILITIES:
Accounts payable	57,432	197,827
Accrued expenses	36,416	41,841
Accrued dividends	163,555	1,333
Contract liabilities	264,472	4,892
Payroll liabilities	0	13,521
Promissory note	0	40,998
Total current liabilities	521,875	300,412
Total liabilities	521,875	300,412
COMMITMENTS AND CONTINGENCIES	0	0
STOCKHOLDERS' EQUITY:
Common stock, $0.001 par value, 250,000,000 shares authorized, 15,424,394 and 12,549,394 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively	15,424	12,549
Additional paid-in capital	12,456,989	12,171,274
Accumulated deficit	(8,198,785)	(5,676,091)
Total stockholders' equity	4,273,634	6,507,739
Total liabilities and stockholders' equity	4,795,509	6,808,151
Series C Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY:
Preferred stock, Value	4	5
Series D Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY:
Preferred stock, Value	$ 2	$ 2

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	100,000,000
Common stock, shares issued	15,424,394	12,549,394
Common stock, shares outstanding	15,424,394	12,549,394
Series C Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	3,501	4,662
Preferred Stock, shares outstanding	3,501	4,662
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	2,000	2,000
Preferred Stock, shares outstanding	2,000	2,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues	$ 296,677	$ 107,813
Cost of sales	202,049	61,680
Gross Profit	94,628	46,133
Operating Expenses:
Selling expenses	65,015	77,139
General and administrative	1,850,225	1,333,371
Professional fees	662,633	696,222
Research and development	38,948	0
Total operating expenses	2,616,821	2,106,732
Loss from operations	(2,522,193)	(2,060,599)
Other Income (Expenses):
Other income	0	13,333
Interest expense	(501)	(32,417)
Total Other Expenses, Net	(501)	(19,084)
Loss Before Income Taxes	(2,522,694)	(2,079,683)
Provision for income taxes	0	0
Net Loss	$ (2,522,694)	$ (2,079,683)
Net Loss Per Share - Basic and Diluted	$ (0.17)	$ (0.25)
Weighted Average Number of Shares Outstanding During the Period - Basic and Diluted	14,714,533	8,175,639

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock Series A	Preferred Stock Series B	Preferred Stock Series C	Preferred Stock Series D	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance, beginning at Dec. 31, 2017					$ 420	$ 1,939,832	$ (3,596,408)	$ (1,656,156)
Balance, beginning (shares) at Dec. 31, 2017	80,000	14	12		651,796
Pre-merger issuances and conversions of shares
Pre-merger issuances and conversions of shares (shares)	(80,000)	(6)	(12)		3,548,204
Sale of Series C preferred stock						250,000		250,000
Sale of Series C preferred stock (Shares)			250
Founder stock returned to company					$ (75)	75
Founder stock returned to company (Shares)					(75,000)
Shares repurchased from shareholder					$ (140)	(210,503)		(210,643)
Shares repurchased from shareholder (Shares)					(139,567)
Conversion of Series B and C preferred stock			$ (2)		$ 1,616	(1,614)
Conversion of Series B and C preferred stock (Shares)		(8)	(2,467)		1,616,470
Exercise of options					$ 56	(56)
Exercise of options (Shares)					55,801
Issuance of common stock for consulting services					$ 185	400,415		400,600
Issuance of common stock for consulting services (Shares)					185,000
AgEagle debt conversion into common stock					$ 788	1,503,015		1,503,803
AgEagle debt conversion into common stock (Shares)					787,891
AgEagle shareholder common stock conversion to Enerjex common shares			$ 2		$ 6,537	(6,539)
AgEagle shareholder common stock conversion to Enerjex common shares (Shares)			2,056		2,757,063
Acquisition of Agribotix					$ 1,275	2,998,725		3,000,000
Acquisition of Agribotix (Shares)					1,275,000
Issuance of common and preferred stock for Enerjex shareholders upon merger					$ 1,887	(762,662)		(760,775)
Issuance of common and preferred stock for Enerjex shareholders upon merger (Share)	0	0	197	0	1,886,736
Issuance of Series C common stock in connection with merger, net of fees	$ 0	$ 0	$ 5	$ 0	$ 0	3,979,995		3,980,000
Issuance of Series C common stock in connection with merger, net of fees (Shares)	0	0	4,626	0	0
Issuance of Series D preferred stock and warrants for cash				$ 2		1,969,998		1,970,000
Issuance of Series D preferred stock and warrants for cash (Shares)				2,000
Share compensation period costs						110,593		110,593
Net loss							(2,079,683)	(2,079,683)
Balance, ending at Dec. 31, 2018			$ 5	$ 2	$ 12,549	12,171,274	(5,676,091)	6,507,739
Balance, ending (shares) at Dec. 31, 2018			4,662	2,000	12,549,394
Shares repurchased from shareholder								0
Conversion of Series C Preferred Stock			$ (1)		$ 2,150	(2,149)
Conversion of Series C Preferred Stock (Shares)			(1,161)		2,150,000
Acquisition of Agribotix					$ 175	(175)
Acquisition of Agribotix (Shares)					175,000
Issuance of common stock for consulting services					$ 550	189,950		190,500
Issuance of common stock for consulting services (Shares)					550,000
Dividend on Series D Preferred Stock						(162,222)		(162,222)
Share compensation period costs						260,311		260,311
Net loss							(2,522,694)	(2,522,694)
Balance, ending at Dec. 31, 2019			$ 4	$ 2	$ 15,424	$ 12,456,989	$ (8,198,785)	$ 4,273,634
Balance, ending (shares) at Dec. 31, 2019			3,501	2,000	15,424,394

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,522,694)	$ (2,079,683)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	171,588	65,362
Stock-based compensation	260,311	110,593
Shares issued for professional services	190,500	400,600
Loss on impairment	162,984	0
Changes in assets and liabilities:
Accounts receivable	(65,740)	163
Inventories	(71,685)	12,836
Prepaid expenses and other assets	(43,793)	(76,986)
Accounts payable	(140,395)	(228,327)
Accrued expenses	(5,425)	(17,513)
Accrued interest	0	28,744
Contract liability	259,580	(1,927)
Payroll liabilities	(13,521)	8,000
Net cash used in operating activities	(1,818,290)	(1,778,138)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(24,445)	0
Cash received in reverse merger	0	256,255
Payments of liabilities assumed in reverse merger	0	(891,474)
Acquisition of Agribotix	0	(925,000)
Net cash used in investing activities	(24,445)	(1,560,219)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of the principle on promissory note	(40,998)	(84,559)
Shares repurchased from shareholder	0	(210,643)
Proceeds from the issuance of Common Stock and Series C convertible preferred stock in connection with merger, net of $20,000 in fees	0	3,980,000
Proceeds from the sale of Series C convertible preferred stock	0	250,000
Proceeds from the issuance of Common Stock Series D	0	1,970,000
Net cash (used in) provided by financing activities	(40,998)	5,904,798
Net (decrease) increase in cash	(1,883,733)	2,566,441
Cash at beginning of period	2,601,730	35,289
Cash at end of period	717,997	2,601,730
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest cash paid	501	39,313
Income taxes paid	0	0
Accrued dividends	163,555	1,333
NONCASH INVESTING AND FINANCING ACTIVITIES:
Assets acquired and (liabilities assumed) in reverse merger cash	0	256,255
Assets acquired and (liabilities assumed) in reverse merger accounts payable	0	(891,474)
Promissory note	0	(125,556)
Net liabilities assumed	0	(760,775)
Conversion of debt into common stock	0	1,503,801
Conversion of Series B and C preferred stock into common stock	2,150	613
Issuance of common stock as consideration	0	3,000,000
Cash paid in the prior year	0	75,000
Deferred revenue	0	6,819
Inventory	0	(3,685)
Fixed assets	0	(7,650)
Intangible assets	0	(724,500)
Goodwill	0	(3,270,984)
Cash paid for acquisition	$ 0	$ (925,000)

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical)	12 Months Ended
	Dec. 31, 2018USD ($)
Statement of Cash Flows [Abstract]
Reverse merger Fees	$ 20,000

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Description of Business	Note 1 – Description of Business AgEagle Aerial Systems Inc. (“AgEagle”, or “the Company”). In addition, providing new utility to UAVs, the Company pioneers, and innovates advanced aerial imaging data collection and analytics technologies capable of addressing the impending food and environmental sustainability crises that threaten our planet. Historically, the Company’s daily efforts have focused on delivering the tools and strategies necessary to define and implement commercial drone construction and delivery, along with sustainability and precision farming solutions that solve important problems confronting the global agricultural industry. In fact, AgEagle has spent eight years serving customers, covering more than two million acres in 50 countries monitoring 53 different crops. AgEagle remains intent on earning distinction as a trusted partner to clients seeking to adopt and support productive agricultural approaches to better farming practices which limit the impact on our natural resources, reduce reliance on inputs and materially increase crop yields and profits. In early 2019, AgEagle further expanded its marketing efforts to provide for the introduction of ParkView In the first half of 2019, the Company introduced HempOverview The Company also designs, produces, distributes and supports technologically advanced small unmanned aerial vehicles (UAVs or drones) that AgEagle offers for commercial sale to the precision agriculture industry. In addition to UAV sales, in late 2018, the Company introduced a new drone-leasing program, alleviating farmers and agribusinesses from significant upfront costs associated with purchasing a drone, while also relieving them from ongoing drone maintenance and support requirements. Additionally, the new program provides the option of engaging a trained AgEagle pilot to operate the drone and manage the entire image collection process, creating a truly turnkey aerial imagery capture solution for its customers. In the third quarter of 2019, AgEagle announced that it had begun to actively pursue expansion opportunities within the emerging Drone Logistics and Transportation market and revealed that it had received its first purchase orders from a major ecommerce company to manufacture and assemble UAVs designed to meet the critical specifications for drones that are meant to carry packaged goods in urban and suburban areas. Central to the Company’s long-term growth strategy, AgEagle will continue to identify opportunities to leverage its proprietary technological platform and industry expertise to penetrate new, high growth market sectors that may benefit from the Company’s advanced aerial imagery-based data collection and analytics solutions. Research and development activities are integral to the Company’s business and it follows a disciplined approach to investing our resources to create new technologies and solutions. In August 2018, the Company acquired certain assets of Agribotix, LLC, a Colorado limited liability company (“Agribotix”), which included Agribotix’s primary product, FarmLens™. The Company believes that by purchasing FarmLens , FarmLens FarmLens The FarmLens FieldView™ FarmLens FieldView FarmLens, In December 2018, AgEagle unveiled its plans to develop a FarmLens Mobile FarmLens FarmLens Mobile The Company is headquartered in Neodesha, Kansas. Corporate History; Recent Business Combinations On March 26, 2018, our predecessor company, EnerJex Resources, Inc. (“EnerJex”), a Nevada company, consummated the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”), dated October 19, 2017, pursuant to which AgEagle Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary of EnerJex, merged with and into AgEagle Aerial Systems Inc., a privately held company organized under the laws of the state of Nevada (“AgEagle Sub”), with AgEagle Sub surviving as a wholly-owned subsidiary of EnerJex (the “Merger”). In connection with the Merger, EnerJex changed its name to AgEagle Aerial Systems Inc. (the “Company, “we,” “our,” or “us”) and AgEagle Sub changed its name initially to “Eagle Aerial, Inc. and then to” AgEagle Aerial, Inc. Prior to the Merger, EnerJex was formerly known as Millennium Plastics Corporation (“Millennium) and was incorporated in the State of Nevada on March 31, 1999. In August 2006, Millennium acquired Midwest Energy, Inc., a Nevada corporation pursuant to a reverse merger. After such merger, Midwest Energy became a wholly-owned subsidiary, and as a result of such merger, the former Midwest Energy stockholders controlled approximately 98% of our outstanding shares of common stock (“Common Stock”). Midwest then changed its name to EnerJex Resources, Inc., (“EnerJex”) in connection with this merger, and in November 2007, it changed the name of Midwest Energy (one of our wholly-owned subsidiaries) to EnerJex Kansas, Inc. (“EnerJex Kansas”). All of its operations conducted prior to this merger were through EnerJex Kansas, Inc., Black Sable Energy, LLC, a Texas limited liability company (“Black Sable”) and Black Raven Energy, Inc. a Nevada corporation (“Black Raven”). Its leasehold interests were held in our wholly-owned subsidiaries Black Sable, Working Interest, LLC, EnerJex Kansas and Black Raven.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Summary of Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation and Consolidation The consolidated financial statements include the accounts of AgEagle Aerial Systems Inc. and its wholly-owned subsidiaries AgEagle Aerial, Inc., EnerJex Kansas, Inc., Black Sable Energy, LLC, Black Raven Energy, Inc. Black Raven Energy, Inc. was dissolved effective November 2019. All significant intercompany balances and transactions have been eliminated in consolidation. The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements. Use of Estimates – Fair Value of Financial Instruments – Cash and Cash Equivalents – Receivables and Credit Polic – The Company estimates an allowance for doubtful accounts based upon an evaluation of the current status of receivables, historical experience, and other factors as necessary. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. The Company determined that no allowance was necessary as of December 31, 2019 and December 31, 2018. Inventorie – Goodwill and Intangible Assets – Intangible assets from acquired businesses are recognized at fair value on the acquisition date and consist of customer programs, trademarks, customer relationships, technology and other intangible assets. Customer programs include values assigned to major programs of acquired businesses and represent the aggregate value associated with the customer relationships, contracts, technology and trademarks underlying the associated program and are amortized on a straight-line basis over a period of expected cash flows used to measure fair value, which ranges from four to five years. Business Combinations Revenue Recognition and Concentration – Revenue from Contracts with Customers Under fixed-price contracts, the Company agrees to perform the specified work for a pre-determined price. To the extent the Company’s actual costs vary from the estimates upon which the price was negotiated, it will generate more or less profit or could incur a loss. The Company accounts for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company generally recognizes revenue on sales to customers, dealers and distributors upon satisfaction of performance obligations which generally occurs once controls transfer to customers, which is when product is shipped or delivered depending on specific shipping terms. As a result of the Agribotix acquisition, the Company now has an additional product line which is the sale of subscription services for use of the FarmLens Sales concentration information for customers comprising more than 10% of the Company’s total net sales such customers is summarized below: Percent of total sales for year ended December 31, Customers 2019 2018 Customer A 90.8 % 10.4 % Customer B * 18.0 % Accounts receivables due from Customer A comprised all of the accounts receivable as of December 31, 2019. The table below reflects our revenue for the periods indicated by product mix. For the Year Ended December 31, Type 2019 2018 Drone Assembly and Product Sales $ 267,622 $ 93,219 Subscription Sales 29,055 14,594 Total $ 296,677 $ 107,813 Vendor Concentration – FarmLens Shipping Costs – Research and Development Expenses - Earnings Per Share – Potentially Dilutive Securities – Income Taxes – Accounting for Income Taxes Stock-Based Compensation Awards – “Compensation – Stock Compensation”, The Black-Scholes option-pricing model requires the input of certain assumptions that require the Company’s judgment, including the expected term and the expected stock price volatility of the underlying stock. The assumptions used in calculating the fair value of stock-based compensation represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change resulting in the use of different assumptions, stock-based compensation expense could be materially different in the future. Recently Issued Accounting Pronouncements – Adopted In January 2016, the FASB issued ASU 2016-01, Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, FASB issued Account Standards Update 2016-02 – Leases In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In January 2017, the FASB issued ASU 2017-01, Business Combinations—Clarifying the definition of a business In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other In May 2017, the FASB issued ASU 2017-09, Compensation—Stock Compensation Pending Adoption In August 2018, the FASB issued ASU 2018-13, Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement In August 2018, the FASB issued ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract Other recent accounting pronouncements issued by FASB did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Business Acquisition

Business Acquisition	12 Months Ended
	Dec. 31, 2019
Business Combinations [Abstract]
Business Acquisition	Note 3 — Business Acquisition On August 28, 2018, the Company closed the transactions contemplated by the Asset Purchase Agreement (the “Purchase Agreement”) dated July 25, 2018 with AgEagle Aerial, Inc., a wholly-owned subsidiary of the Company, Agribotix, LLC, a Colorado limited liability company (sometimes also referred to herein as” Agribotix” or the “Seller”), and the other parties named therein. The Company acquired, all right, title and interest in and to all assets owned by the Seller utilized in the Seller’s business of providing integrated agricultural drone solutions and drone-enabled software technologies and services for precision agriculture, except for certain excluded assets as set forth in the Purchase Agreement (the “Purchased Assets”). At closing, the Company assumed certain liabilities under various third-party contracts pursuant to the terms of the Purchase Agreement. The consideration for the Purchased Assets made at closing included the following: (a) a cash payment of $150,000 (of which $110,000 was previously paid), (b) 200,000 shares of Common Stock of the Company at a value of $5.00 per share (all of which shares were issued to the Seller pursuant to an exchange agreement between the Company and the Seller dated as of November 20, 2017), (c) an amount payable at closing equal to the sum of: (i) 500,000 shares of Common Stock at a value of $2.00 per share (the “Closing Shares”); and (ii) $450,000 in cash. In addition, the Seller paid on the 90th day following the closing equal to the sum of: (i) the number of shares of Common Stock that is calculated by dividing $2,000,000 by the $2.00 share and (ii) $400,000 in cash. The Purchase Agreement contains customary representations, warranties and covenants, including provisions for indemnification in the event of any damages suffered by either party as a result of, among other things, breaches of representations and warranties contained therein. An aggregate amount equal $75,000 in cash, 50% of the number of Closing Shares and 25% of the number of Post-Closing Shares were deposited in an escrow account with a third-party escrow agent to secure the indemnification obligations of the Seller pursuant to the terms of the Purchase Agreement. As of December 31, 2019, the entire amount remains in escrow. In accordance with ASC 805, “Business Combinations,” the Company accounted for the acquisition of Agribotix using the acquisition method of accounting. The purchase price was allocated to specific identifiable tangible and intangible assets at their respective fair values at the date of acquisition. The following table summarizes the total fair value of the consideration transferred as well as the fair values of the assets acquired and liabilities assumed. Common Stock consideration $ 3,000,000 Cash paid 1,000,000 Total purchase consideration 4,000,000 Inventory (3,685 ) Property and equipment (7,650 ) Intangibles assets (724,500 ) Contract liabilities 6,819 Goodwill $ 3,270,984 Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the expected revenue and benefits of the combined company. As noted above, control was obtained on August 28, 2018, the closing date of the transactions contemplated by the Purchase Agreement, at which time the Company took over the operations of Agribotix and personnel. The accompanying consolidated financial statement includes the activity of Agribotix for the period after the acquisition commencing August 29, 2018. The following unaudited proforma financial information gives effect to the Company’s acquisition of Agribotix as if the acquisition had occurred on January 1, 2018 and had been included in the Company’s consolidated statement of operations for the year ended December 31, 2018: For the year ended December 31, 2018 Revenue $ 314,486 Net Loss $ (2,702,928 )

Inventories

Inventories	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventories	Note 4 — Inventories Inventories consist of the following at: December 31, 2019 2018 Raw materials $ 193,022 $ 109,826 Work-in process 26,456 30,088 Finished goods 11,689 19,937 Gross inventory 231,167 159,851 Less obsolecense reserve (10,000 ) (10,369 ) Total $ 221,167 $ 149,482

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5 — Property and Equipment Property and equipment consist of the following at: December 31, 2019 2018 Property and equipment $ 140,758 $ 116,313 Less accumulated depreciation (102,982 ) (87,939 ) $ 37,776 $ 28,374 Depreciation expense for the years ended December 31, 2019 and 2018 was $15,043 and $17,980, respectively.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Note 6 — Goodwill and Intangible Assets Intangible assets are recorded at cost and consist of the assets acquired for the acquisition of Agribotix completed in 2018 (see Note 3). Goodwill and intangible assets were comprised of the following as of December 31, 2019: Estimated Life Balance at January 1, 2019 Accumulated Amortization Impairment Balance at December 31, 2019 Intellectual Property/Technology 5 Years $ 433,400 $ (115,574 ) $ — $ 317,826 Customer Base 5 Years 72,000 (19,200 ) — 52,800 Tradenames and Trademarks 5 Years 58,200 (15,520 ) — 42,680 Non-compete Agreement 4 Years 160,900 (53,633 ) — 107,267 Total intangible assets 724,500 (203,927 ) — $ 520,573 Goodwill 3,270,984 — (162,984 ) 3,108,000 Total $ 3,995,484 $ $ (162,984 ) $ 3,628,573 The weighted average remaining amortization period in years is 3.5 years. Future amortization is as follows for fiscal years ending: 2020 2021 2022 2023 Intellectual Property/Technology $ 86,680 $ 86,680 $ 86,680 $ 57,786 Customer Base 14,400 14,400 14,400 9,600 Tradenames and Trademarks 11,640 11,640 11,640 7,760 Non-compete Agreement 40,225 40,225 26,817 — Total $ 152,945 $ 152,945 $ 139,537 $ 75,146 In the fourth quarter of 2019, the Company performed its annual goodwill impairment test using a quantitative approach by comparing the carrying value of the reporting unit, including goodwill, to its fair value. If the carrying value of the reporting unit, including goodwill, exceeds its fair value, a goodwill impairment loss is recognized in an amount equal to that excess. The Company estimates the fair value of each reporting unit using a combination of a discounted cash flow (DCF) (Level 3 input) analysis and market-based valuation methodology such as comparable public company trading values and values observed in recent business acquisitions. Determining fair value requires the exercise of significant judgments, including the amount and timing of expected future cash flows, long-term growth rates, discount rates and relevant comparable public company earnings multiples and relevant transaction multiples. The cash flows employed in the DCF analysis are based on estimates of future sales, earnings and cash flows after considering factors such as general market conditions, existing firm orders, expected future orders, changes in working capital, long term business plans and recent operating performance. The DCF analysis used a discount rate of 27%. The fair value of the reporting unit was found to be less than it’s carrying value. During the year ended December 31, 2019, a goodwill impairment charge of $162,984 was recognized which is included in general and administrative expenses on the statements of operations. Due to the goodwill impairment charge, the company tested its finite-lived intangible assets for impairment. For purposes of testing the finite-lived intangible assets the sum of the undiscounted future cash flows expected to result from the use of the asset group was compared to the asset group’s carrying value. Based on the impairment test for the finite-lived intangibles assets related to the Agribotix reporting unit no impairment exists for those assets as of December 31, 2019. The Company will continue to amortize the related finite-intangible asset over their estimated useful lives.

Debt

Debt	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Debt	Note 7 – Debt Convertible Notes Payable On May 6, 2015, the Company closed a private placement pursuant to a subscription agreement whereby two institutional investors (the “2015 Holders”) purchased convertible notes having an aggregate principal amount of $500,000, convertible into Common Stock of the Company at $2.00 per share and maturing on November 6, 2016. Interest on the notes accrued at a rate of 8% annually and was payable quarterly. It was determined that there were no aggregate beneficial conversion features. On or about March 4, 2016, the Company and the 2015 Holders entered into extension and modification agreements whereby the 2015 Holders agreed to extend the maturity date of the notes to November 6, 2016, and permanently waive all rights and remedies, of whatever nature, with respect to the various defaults that occurred under this subscription agreement and notes, including, without limitation, (I) the Company’s failure to become a public SEC reporting company on or before September 30, 2015, (ii) the Company’s failure to pay interest on the notes, and (iii) modifying and waiving certain participation rights in future financings. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $9,111of interest expense, respectively. As of the Merger Date, the principal amount of the promissory note of $500,000 and its accrued interest of $114,556 were converted at $1.25 per share into 814,381 shares of Common Stock. On September 6, 2016, the Company closed a private placement pursuant to a subscription agreement whereby an existing institutional investor (the “2016 Holder”) purchased a convertible note having a principal amount of $300,000, convertible into shares of Common Stock of the Company at $3.00 per share and maturing on September 30, 2017. Interest on the note accrues at a rate of 8% annually and is payable quarterly. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded interest expense of $0 and $5,467, respectively. As of the Merger Date, the principal amount of the promissory note of $300,000 and its accrued interest of $42,933 were converted at $1.25 per share into 454,440 shares of Common Stock. On February 3, 2017, the Company closed a private placement pursuant whereby a bridge loan (the “2017 Note A”) agreement was executed with an accredited investor (the “2017 Holder Note A”) to purchase a convertible promissory note with an aggregate principal amount of $175,000, an original issue discount of $25,000, convertible into shares of Common Stock of the Company at $2.50 per share and maturing 90 days following issuance, or May 4, 2017. After payment of a finder’s fee and other expenses, the Company received net proceeds of $101,250. In addition, the Company also issued to the 2017 Holder Note A warrant to purchase 200,000 shares of the Company’s Common Stock at an exercise price per share of $2.50. To the extent the entire unpaid principal balance of the note is not paid in full on the maturity date, (i) interest on the unpaid principal balance will accrue from the maturity date at the rate of 18% per annum, and will continue until the date the note is paid in full, and (ii) the Company will issue to the 2017 Holder Note A an additional warrant to purchase 100,000 shares of Common Stock for each ninety (90) calendar day period that the unpaid principal balance of the note and any accrued interest is not paid in full by such date. Upon conversion as of Merger Date, the Company had issued an additional 300,000 warrants to purchase shares resulting from the default of the loan. For the year ended December 31, 2019, the Company recorded $0 of interest expense. For the year ended December 31,2018 the Company recorded interest expense of $ 7,077. As of the date of the merger on March 26, 2018, the principal amount of the promissory note of $175,000 and its accrued interest of $35,642 were converted at $2.50 per share into 139,567 shares of Common Stock. On July 2017, the Company closed a private placement pursuant to a subscription agreement whereby an existing institutional investor (the “2017 Note B”) purchased a convertible note having a principal amount of $100,005, convertible into Common Stock of the Company at $2.00 per share and maturing on February 28, 2018. Interest on the note accrues at a rate of 8% annually payable upon maturity. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $1,822 of interest expense, respectively. As of the Merger Date, the principal amount of the promissory note of $100,005 and its accrued interest of $5,600 were converted at $1.25 per share into 139,943 shares of Common Stock. On September 2017, the Company closed a private placement pursuant to a subscription agreement whereby an existing institutional investor (the “2017 Note C”) purchased a convertible note having a principal amount of $35,000, convertible into shares of Common Stock of the Company at $2.00 per share and maturing on February 28, 2018. Interest on the note accrues at a rate of 8% annually payable upon maturity. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $638 of interest expense, respectively. As of the Merger Date, the principal amount of the promissory note of $35,000 and the accrued interest of $1,369 were converted at $1.25 per share into 48,194 shares of Common Stock. On October 2017, the Company closed a private placement pursuant to a subscription agreement whereby an existing institutional investor purchased a convertible note having a principal amount of $50,000, (the “2017 Note D”) convertible into shares of Common Stock of the Company at $2.00 per share and maturing on February 28, 2018. Interest on the note accrues at a rate of 8% annually payable upon maturity. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $911 of interest expense, respectively. As of the Merger Date, the principal of $50,000 and the accrued interest of $1,722 were converted at $1.25 per share into 68,540 shares of Common Stock. Promissory Notes On December 15, 2016, the Company issued a promissory note with an aggregate principal amount of $30,000 to a shareholder of the Company. On January 24, 2017, the Company issued a second promissory note with an aggregate principal amount of $30,000 to the same related party. On September 14, 2017, the Company issued a third promissory note with an aggregate principal amount of $16,050 to the same shareholder. All three promissory notes (the “Related Party Notes A”) accrue interest at an annual rate of 2% and matured on November 6, 2017. On or about August 1, 2017, the Company and the shareholder promissory note A holder entered into extension and modification agreements whereby they agreed to extend the maturity date of the Related Party Notes A to February 28, 2018, added a conversion feature whereby the debt can be converted into shares of Common Stock of the Company at $2.00 per share and amended the interest rate on the note retroactively to accrue at a rate of 8% annually. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $1,386 of interest expense, respectively. As of the Merger Date, the principal of $76,050 and the accrued interest of $7,239 were converted at $1.25 per share into 110,371 shares of Common Stock. On March 5, 2017, the Company issued a promissory note with an aggregate principal amount of $10,000 to an executive of the Company. On May 15, 2017, the Company issued a second promissory note with an aggregate principal amount of $10,000 to the same executive of the Company. On September 15, 2017, the Company issued a 3 rd rd As of the Merger Date, all the AgEagle shares of Common Stock issued in connection with conversion of debt noted above were subsequently converted into EnerJex shares and then split at a rate of 25 to 1 resulting in a conversion rate of 1.6564 per AgEagle share into a total of 787,891 shares of EnerJex Common Stock and 1,631 shares of Series C Preferred Stock. On March 26, 2018, as part of the liabilities assumed from the EnerJex Merger, the Company recorded a promissory note for a principal amount of $125,556 and accrued interest of $4,171 payable over twelve months and maturing on March 27, 2019. As of December 31, 2019, the promissory note has been paid in full resulting in principal payments of $40,998 made during the first four months of 2019. The Company recorded interest expense of $501 for 2019 related to this promissory note.

Equity

Equity	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Equity	Note 8 – Equity Capital Stock Issuances As a result of the Merger all the holders of the Company’s 10% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) had their shares automatically converted into 902,186 shares of the Company’s Common Stock. The Company’s Series B Convertible Preferred Stock of 8.25 shares (the “Series B Preferred Stock”) remained outstanding and were convertible into 5,388 shares of the Company’s Common Stock. The Company’s Series C Convertible Preferred Stock (the “Series C Preferred Stock”) included 2,879 of remaining shares after the conversion and retirement of all the Company’s promissory notes due. These shares are convertible into 1,471,425 shares of the Company’s Common Stock. Furthermore, an additional 4,000 shares of Series C Preferred Stock were issued and are convertible into 3,020,797 shares of the Company’s Common Stock, as they were issued to the current holder of Series C Preferred Stock in connection with a $4 million financing of Series C Preferred Stock (the “Financing”). On May 11, 2018, we issued an additional 250 shares of our Series C Preferred Stock, convertible into 163,265 shares of our Common Stock and received a cash payment of $250,000 for the issuance of the Series C Preferred Stock. The Series C Preferred Stock includes a beneficial ownership limitation preventing conversion of shares of Series C Preferred Stock into more than 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of the Series C Preferred Stock. On April 16, 2018, Alpha Capital Anstalt converted 8.25 shares of Series B Preferred Stock, representing the last of the outstanding Series B shares, into 5,388 shares of Common Stock at a conversion price of $1.53. During the year ended December 31, 2018, Alpha Capital Anstalt converted 2,467 shares of Series C Preferred Stock into 1,611,082 shares of Common Stock at a conversion price of $1.53. In connection with an investor relations agreement, dated April 4, 2018, the Company issued 60,000 shares of its Common Stock to the investor relations firm, and its designees, and agreed to register such shares on its next registration statement (the “Registration Rights”). On July 24, 2018, in connection with the filing of the Company’s registration statement on form S-1, a waiver of the Registration Rights was obtained from the investor relations firm in exchange for 125,000 additional shares, which were issued by the Company and approved by the Board. The Company recognized a total of $400,415 of investor relations expense at a fair value of $2.12 and $2.26 per share within general and administrative costs related to these issuances. On August 28, 2018 and 90 days thereafter, pursuant to the Purchase Agreement for Agribotix, the Company issued 1,275,000 shares at a $2.00 share price. On December 4, 2018, our former board director Mr. Scott Burell exercised 60,724 options at an exercise price of $0.06 resulting in the issuance of 55,801 shares as due to the Company’s withholding obligation relating to the exercise of these options some shares were held back. During the twelve months ended December 31, 2019, Alpha Capital Anstalt converted a total of 1,161 shares of Series C Preferred Stock into 2,150,000 shares of Common Stock at a conversion price of $0.54. On June 18, 2019, the Company issued in connection with a consulting agreement, dated May 3, 2019, 500,000 shares of its Common Stock to the consulting company as a part of their compensation for services. The Company recognized a total of $170,000 of investor relations expense at a fair value of $0.34 per share within general and administrative costs related to these issuances. On June 18, 2019, the Company issued in connection with an investor relations agreement, dated April 4, 2018, 50,000 shares of its Common Stock to the investor relations firm. The Company recognized a total of $20,500 of investor relations expense at a fair value of $0.41 per share within general and administrative costs related to these issuances. This agreement was terminated in March 2019. Series C Preferred Stock On November 21, 2017, Alpha Capital Anstalt (“Alpha”) signed a binding commitment letter with EnerJex to provide prior to or at the closing of the Merger a minimum of $4 million in new equity capital (the “Private Placement”). The Private Placement was consummated on March 26, 2018. In connection with the Private Placement, Alpha purchased an additional 4,000 shares of Series C Preferred Stock at a purchase price of $1,000 per share for total aggregate consideration of $4 million. At the time of the private placement, the Series C Preferred Stock was convertible into 2,612,245 shares of our Common Stock. In addition, as consideration for their funding commitment, Alpha received a fee equal to 408,552 shares of our Common Stock. Each share of Series C Preferred Stock is convertible into a number of shares of our Common Stock equal to the quotient determined by dividing (x) the stated value of $1,000 per share, by (y) a conversion price of $0.54. Until the volume weighted average price of our Common Stock on NYSE exceeds $107.50 with average trading volume of 200,000 shares per day for ten consecutive trading days, the conversion price of our Series C Preferred Stock is subject to full-ratchet, anti-dilution price protection. Under that provision, if, while that full-ratchet, anti-dilution price protection is in effect, the Company issues shares of our Common Stock at a price per share (the “Dilutive Price”) that is less than the conversion price, then the conversion price of our Series C Preferred Stock is automatically reduced to be equal to the Dilutive Price. The effect of that reduction is that, upon the issuance of shares of Common Stock at a Dilutive Price, the Series C Preferred Stock would be convertible into a greater number of shares of our Common Stock. Series D Preferred Stock On December 27, 2018, AgEagle Aerial Systems Inc. (the “Company”) entered into Securities Purchase Agreement (the “Agreement”) with an institutional investor (the “Purchaser”). Pursuant to the terms of the Agreement, the Board of Directors of the Company (the “Board”) designated a new series of preferred stock, the Series D Preferred Stock, which is non-convertible and provides for an 8% annual dividend and is subject to optional redemption by the Company (the “Preferred Stock”). The Company issued 2,000 shares of Preferred Stock and a warrant (the “Warrant”) to purchase 3,703,703 shares of the Company’s Common Stock, par value $0.001 per share (the “Common Stock”), for $2,000,000 in gross proceeds. The shares of Common Stock underling the Warrant are referred to as the “Warrant Shares”. The Company also entered into a registration rights agreement (the “Registration Rights Agreement”) granting registration rights to the Purchaser with respect to the Warrant Shares. The Agreement provides that upon a subsequent financing or financings with net proceeds of at least $500,000, the Company must exercise its optional redemption of the Preferred Stock and apply any and all net proceeds from such financing(s) to the redemption in full of the Preferred Stock. The Preferred Stock is nonconvertible, provides for an 8% annual dividend payable semi-annually, and has liquidation rights senior to the Common Stock, but pari passu with the Company’s Series C Preferred Stock. The Preferred Stock has no voting rights, except that the Company shall not undertake certain corporate actions as set forth in the Certificate of Designation that would materially impact the holders of Preferred Stock without their consent. The Preferred Stock is subject to optional redemption by the Company at 115% of the stated value of the Preferred Stock outstanding at the time of such redemption, plus any accrued but unpaid dividends and all liquidated damages or other amounts due. Any such optional redemption may only be exercised after giving notice and upon satisfaction of certain equity conditions set forth in the Certificate of Designation, including (i) all dividends, liquidated damages and other amounts have been paid; (ii) there is an effective registration statement covering the Warrant Shares, or the Warrant Shares can be exercised through a cashless exercise without restriction under Rule 144, (iii) the Warrant Shares are listed on an exchange, (iv) the holder is not in possession of material, non-public information, (v) there is a sufficient number of authorized shares for issuance of all Warrant Shares, and (vi) for each trading day in a period of 20 consecutive trading days prior to the redemption date, the daily trading volume for the Common Stock on the principal trading market exceeds $200,000 per trading day. Options Issued On March 26, 2018, the EnerJex 2017 Omnibus Equity Incentive Plan (the “Plan”) became effective. Under the Plan, the Company can grant equity-based and other incentive awards to officers, employees and directors of, and consultants and advisers to, the Company. The purpose of the Plan is to help the Company attract, motivate and retain such persons and thereby enhance shareholder value. The Plan shall continue in effect, unless sooner terminated, until the tenth (10th) anniversary of the date on which it is adopted by the Board of Directors (except as to awards outstanding on that date). The Board of Directors in its discretion may terminate the Plan at any time with respect to any shares for which awards have not theretofore been granted; provided, however, that the Plan’s termination shall not materially and adversely impair the rights of a holder, without the consent of the holder, with respect to any award previously granted. On June 18, 2019, at the Annual Meeting of Shareholders of the Company, the shareholders approved a proposal to increase the number of shares of Common Stock reserved for issuance under the Plan from 2,000,000 to 3,000,000. To the extent that an award lapses, expires, is canceled, is terminated unexercised or ceases to be exercisable for any reason, or the rights of its holder terminate, any shares subject to such award shall again be available for the grant of a new award. The number of shares for which awards which are options or SARs may be granted to a participant under the Plan during any calendar year is limited to 500,000. For purposes of qualifying awards as “performance-based” compensation under Code Section 162(m), the maximum amount of cash compensation that may be paid to any person under the Plan in any single calendar year shall be $500,000. During the year ended December 31, 2019, the Company issued options to purchase 1,131,000 shares of Common Stock to directors and employees of the Company at exercise prices ranging from $0.29 to $0.54 per share expiring on dates between December 31, 2023 and March 28, 2029. The Company determined the fair-market value of the options to be $269,700. In connection with the issuance of these options to employees and directors, the Company recognized $58,491 in stock compensation expense for the year ended December 31, 2019. During the year ended December 31, 2018, the Company issued options to purchase 534,598 shares of Common Stock to directors and employees of the Company at exercise prices ranging from $0.51 to $4.33 per share expiring on dates between March 30, 2023 and December 15, 2028. The Company determined the fair-market value of the options to be $387,052 . In connection with the issuance of these options to employees and directors, the Company recognized $196,485 and $102,698 in stock compensation expense for the years ended December 31, 2019 and 2018. On October 4, 2017, AgEagle Sub issued options to purchase 927,775 shares of Common Stock to employees and directors, that were approved by the Board at an exercise price of $0.06 per share. These options were assumed by the Company in the Merger. In connection with the issuance of these options to employees and directors, the Company recognized $5,335 and $7,895 in stock compensation expense for the years ended December 31, 2019 and 2018. The fair value of options granted during the year ended December 31, 2019 and 2018 were determined using the Black-Scholes option valuation model. The expected term of options granted is based on the simplified method in accordance with Securities and Exchange Commission Staff Accounting Bulletin 107 and represents the period of time that options granted are expected to be outstanding. The Company makes assumptions with respect to expected stock price volatility based on the average historical volatility of peers with similar attributes. In addition, the Company determines the risk-free rate by selecting the U.S. Treasury with maturities similar to the expected terms of grants, quoted on an investment basis in effect at the time of grant for that business day. The significant assumptions relating to the valuation of the Company’s stock options granted during the years ended December 31, 2019 were as follows: December 31, 2019 Dividend yield 1.62% Expected life 3.0-6.1 Years Expected volatility 82.38-88.62% Risk-free interest rate 1.56-2.23% A summary of the options activity for the year ended December 31, 2019 is as follows: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2019 1,494,158 $ 0.46 6.93 years $ 417 ,504 Granted 1,131,000 0.37 6.27 years — Exercised/Forfeited (144,688 ) 0.99 —years — Outstanding at December 31, 2019 2,480,470 0.39 6.28 years 378,111 Exercisable at period end 1,521,859 $ 0.36 6.10 years $ 301 ,051 For options granted during the year ended December 31, 2019, the fair value of the Company’s stock was based upon the close of market price on the date of grant. The future expected stock-based compensation expense expected to be recognized in future years is $259,194 through March 31, 2022. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at December 31, 2019 (for outstanding options), less the applicable exercise price. A summary of the options activity for the years ended December 31, 2018 is as follows: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2018 1,134,830 $ 0.06 8.5 years $ — Granted 534,598 1.35 5.94 years $ — Cancelled (175,270 ) 0.60 —years $ — Outstanding at December 31, 2018 1,494,158 $ 0.46 6.93 years $ 417,504 Exercisable at end of the year 782,147 $ 0.22 7.07 years $ 356,979 On March 1, 2015, AgEagle Sub entered into a strategic consulting agreement with a related party and granted 207,055 stock options exercisable over five years from the grant date at an exercise price per share of $2.60. On October 4, 2017, AgEagle Sub held a board meeting to approve the modification of the existing 207,055 options to purchase Common Stock from an exercise price of $2.60 to $0.06 per share. These options were assumed by the Company in the Merger. In connection with these options, the Company recognized no stock compensation expense for the year ended December 31, 2018 as they were all fully vested. The significant assumptions relating to the valuation of the Company’s stock options granted during the year ended December 31, 2018 were as follows: December 31, 2018 Dividend yield 0% Expected life 3.5-7.0 Years Expected volatility 76.04% to 80.5% Risk-free interest rate 2.59% to 3.01 For options granted in 2018, the fair value of the Company’s stock was obtained per the close of market as of December 31, 2018.

Warrants to Purchase Common Sto

Warrants to Purchase Common Stock	12 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Warrants to Purchase Common Stock	Note 9 – Warrants to Purchase Common Stock Warrants Issued As of December 31, 2019, the Company had outstanding warrants, in connection with the issuance of debentures in 2017, to purchase 828,221 shares of the Company’s Common Stock at an exercise price of $1.51 with an expiration date on August 2, 2024. On December 27, 2018, the Company issued 2,000 shares of Preferred Stock and a warrant (the “Warrant”) to purchase 3,703,703 shares of the Company’s Common Stock for $2,000,000 in gross proceeds. The shares of Common Stock underlying the Warrant are referred to as the “Warrant Shares.” The Company also entered into a registration rights agreement (the “Registration Rights Agreement”) granting registration rights to the Purchaser with respect to the Warrant Shares. The Warrant is exercisable for a period of five years through December 26, 2023 at an exercise price equal to $0.54 per share; and is subject to customary adjustments for stock splits dividend, rights offerings, pro rata distributions and fundamental transactions. In addition, in the event the Company undertakes a subsequent equity financing or financings at an effective price per share that is less than $0.54, the exercise price of the Warrant shall be reduced to the lower price. The Warrant provides that the Warrant holder shall have a “Beneficial Ownership Limitation” equal to 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Warrant holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation, as provided for in the Warrant. All warrants outstanding as of December 31, 2019 are scheduled to expire between December 26, 2023 and October 21, 2024. A summary of activity related to warrants for the year ended December 31, 2019 follows: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Outstanding at January 1, 2019 4,531,924 $ 0.72 5.05 Outstanding at December 31, 2019 4,531,924 $ 0.72 5.05 Exercisable at December 31, 2019 4,531,924 $ 0.72 4.05 A summary of activity related to warrants for the twelve months ended December 31, 2018 follows: Shares Weighted- Average Exercise Price ($) Weighted-Average Remaining Contractual Term Outstanding at January 1, 2017 828,221 $ 1.51 5.34 Granted 3,703,703 $ 0.54 4.99 Outstanding at December 31, 2018 4,531,924 $ 0.72 5.05 Exercisable at December 31, 2018 4,531,924 $ 0.72 5.05

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10 – Commitments and Contingencies Operating Leases The Company leases office space located at 117 South 4 th As a result of the Agribotix acquisition, the Company assumed a lease for offices in Boulder, Colorado for $2,000 a month. The lease ended on May 31, 2019 and the Company renewed the lease for another year with an option to terminate at any time with a 30-day prior notice period. Rent expense was $30,000 and $13,600 for the years ended December 31, 2019 and 2018, respectively, which is included in general and administrative expenses on the statements of operations. Merger Agreement On March 26, 2018, EnerJex Resources, Inc. (“EnerJex”), a Nevada company, consummated the transactions contemplated by that certain Agreement and Plan of Merger, dated October 19, 2017, pursuant to which AgEagle Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary of EnerJex, merged with and into AgEagle Aerial Systems Inc., a privately held company organized under the laws of the state of Nevada (“AgEagle Sub”), with AgEagle Sub surviving as a wholly-owned subsidiary of EnerJex (the “Merger”). In connection with the Merger, EnerJex changed its name to AgEagle Aerial Systems Inc. (the “Company”) and AgEagle Sub changed its name to “Eagle Aerial Systems, Inc.” The Company’s Common Stock will continue to trade on the NYSE American under its new symbol “UAVS” commencing on March 27, 2018. As a result of the Merger, through AgEagle Sub, the Company is now engaged in the business of designing, developing, producing, distributing and supporting technologically-advanced small unmanned aerial vehicles (UAVs or drones) that it supplies to the precision agriculture industry. Each share of Common Stock issued and outstanding and underlying options and warrants of AgEagle Sub outstanding immediately prior to the Merger was exchanged for 1.66 shares of Company Common Stock (the “Exchange Ratio”). As a result, at the effective time of the Merger (the “Effective Time”), 5,439,526 shares of AgEagle Sub’s capital stock, representing all currently outstanding shares of Common Stock and all other debt or equity securities convertible into Common Stock (except options and warrants as described below) were automatically converted into 7,944,941 shares of Company Common Stock. In addition, at the Effective Time, 685,100 outstanding options and 500,000 warrants to purchase shares of AgEagle Sub Common Stock were assumed by EnerJex and converted into 1,134,830 options and 828,221 warrants to purchase shares of Common Stock of the Company. All holders of EnerJex’s 10% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) had their shares automatically converted into 896,640 shares of the Company’s Common Stock. EnerJex’s Series B Convertible Preferred Stock (the “Series B Preferred Stock”) remains outstanding, and 1,624 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) are now convertible into 1,060,432 shares of Company Common Stock. Furthermore, an additional 5,051 shares of Series C Preferred Stock, convertible into 3,298,348 shares of Company Common Stock, were issued to the current holder of Series C Preferred Stock in connection with a $4 million financing of Series C Preferred Stock (the “Financing”) and the conversion and retirement of $425,000 in prior EnerJex promissory notes due and owing to such holder. As of the Effective Time, the former shareholders of AgEagle Sub owned approximately 67% of the Company’s Common Stock (inclusive of the AgEagle Sub assumed stock options and warrants), the former EnerJex holders of Common Stock, the Series A Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock, which were outstanding immediately prior to the Financing, collectively own 12.7% of the Company’s Common Stock on a fully-diluted basis. In connection with the Merger, AgEagle waived the requirement for EnerJex to have paid and satisfied in full all outstanding indebtedness of EnerJex such that there would be no continuing liabilities of EnerJex subsequent to the closing of the Merger (“Liability Condition”). In consideration for AgEagle waiving the Liability Condition, the 1,215,278 shares of Common Stock to be held in escrow (valued at $350,000) owned by certain former principal stockholders, officers and directors of EnerJex to secure losses, if any, that may be suffered by the AgEagle indemnified parties pursuant to the indemnification obligations under the Merger Agreement, were never issued and such former principal stockholders, officers and directors are not entitled to receive such shares. However, such former principal stockholders, officers and directors received, in the aggregate, deferred salaries and fees valued at approximately $297,500. In lieu of payment of the deferred salaries and fees in cash, such amounts have been converted into an aggregate of 1,032,986 shares of Company Common Stock. Prior to the Merger, EnerJex operated as an oil exploration and production company engaged in the acquisition, development, exploration and production of oil in Eastern Kansas. In connection with the Merger, EnerJex disposed of its principal assets, consisting primarily of its Kansas oil and gas properties. GreenBlock Capital LLC Consulting Agreement On May 3, 2019, the Company entered into a consulting agreement with GreenBlock Capital LLC (“Consultant”) to serve as strategic advisor and consultant to the Company with respect to the development of business opportunities and the implementation of business strategies to be agreed to by both parties. The extent of the services will be set forth in separate scopes of work, from time to time, to be prepared and mutually agreed to by the parties. As compensation for the services under the terms of the agreement, Consultant shall receive (i) $25,000 per month during the term of the agreement, (ii) 500,000 shares of restricted Common Stock upon execution of the agreement, and (iii) up to 2,500,000 shares of restricted Common Stock upon the achievement of predetermined milestones. The Consultant was also previously engaged by the Company between March 2015 and August 2016 to provide consulting services. The Consultant beneficially owns approximately 5.86% of the shares of the Company’s Common Stock issued and outstanding; and holds options to purchase 207,055 shares of the Company’s Common Stock, exercisable until January 14, 2021 at an exercise price of $0.06 per share. On October 31, 2019, the consulting agreement with the Consultant was terminated as a result of the Company no longer needing these services to be provided by an outside consultant. During the term of the agreement, the Company paid to the Consultant (i) $25,000 per month and issued (ii) 500,000 restricted shares of Common Stock at the execution of the agreement. The agreement also provided for the issuance of up to an additional 2,500,000 shares of restricted Common Stock upon the achievement of milestones that were to be determined by the Company and the Consultant during the term of the agreement. There are no early termination penalties incurred as a result of the termination of the consulting agreement. The Consultant may still be entitled to receive the Shares after termination of the Agreement, if the achievement of milestones that commenced during the term of the Agreement are completed after termination. Employment and Board Agreements Ms. Louisa Ingargiola, Director Effective November 27, 2018 Mr. Louisa Ingargiola was appointed as a director of the Board of Directors of the Company, a member of the Compensation and Nominating and Corporate Governance Committee and Chairman of the Audit Committee. Pursuant to her offer letter, Ms. Louisa Ingargiola is entitled to receive for her service on the board: (1) an initial grant of five-year options to purchase 41,250 shares of Common Stock upon appointment, which was at an exercise price of $0.77 (equal to the market price of our Common Stock on the date of grant) that will vest in equal installments every calendar quarter over a one year period; and (2) five-year options to purchase 16,500 shares of Common Stock per calendar quarter of service at an exercise price per share equal to the market price of our Common Stock at the time of issuance that will vest in equal installments every calendar quarter for the two year period after date the grant. Barrett Mooney, Chief Executive Officer Pursuant to an employment offer letter dated July 9, 2018, Mr. Mooney will receive as compensation for his services as Chief Executive Officer a base salary of $220,000 per year, which shall be subject to annual performance review by the Compensation Committee of the Board and may be revised by the Board, in its sole discretion. Mr. Mooney received an initial grant of 75,000 shares of restricted Common Stock of the Company which is fully vested. Mr. Mooney shall also be eligible to receive an award of 75,000 shares of restricted Common Stock of the Company which shall fully vest as of January 1, 2019 if, and only if, the stock price of the Company reaches $3.55 per share and the closing price per share is at or above such price at the end of the day on January 1, 2019. In addition, Mr. Mooney is eligible to receive an award of 20,000 nonqualified stock options under the Company’s 2017 Omnibus Equity Incentive Plan (the “Equity Plan”) upon securing one sustainability pilot program on or before October 31, 2018, and an additional award of 30,000 nonqualified stock options under the Equity Plan upon securing a second sustainability pilot program on or before January 31, 2019. Both awards shall provide for immediate vesting and exercisability at an exercise price equal to the fair market value of the Company’s shares of Common Stock underlying the options as of the date of grant. Mr. Mooney will also be eligible receive an award of up to 55,000 Non-qualified Stock Options under the Equity Plan based upon the results of his annual performance review in the first quarter of 2019. Effective December 18, 2018, an amendment was signed for the original employment offer letter dated July 9, 2018, thereby providing an amendment to provide that in lieu of the issuance of 75,000 shares of restricted Common Stock of the Company (the “Shares”), the Company shall award to Mr. Mooney 125,000 Non-qualified Stock Options (the “Stock Options”) under the Company’s 2017 Omnibus Equity Incentive Plan (the “Equity Plan”). The Stock Options shall be subject to the terms of the Equity Plan and standard option award agreement which shall have a term of 10 years and provide for vesting over a one-year period and exercisability at an exercise price equal to the fair market value of the Company’s Common Stock as of the date of the grant. The award of 75,000 shares were returned to the Company and immediately cancelled. On September 30, 2019, the Board of Directors and the Compensation Committee approved a new compensatory arrangement for Mr. Mooney. Commencing on September 30, 2019, Mr. Mooney shall receive quarterly awards of stock options to purchase 15,000 shares of the Company’s Common Stock under the Company’s current shareholder approved equity incentive plan. The exercise price at the time of the awards shall be based on the fair market value of the Company’s Common Stock on the NYSE American on the date of grant. The options will be issued quarterly for a period of two years, will vest in equal amounts over a two-year term from the date of grant, and will be exercisable for a period of five years from date of grant. Mr. Mooney is also entitled to receive bonuses up to $48,000 in cash, 250,000 shares of restricted stock and 225,000 stock options upon the achievement of certain Company operational milestones. The foregoing compensation arrangements are in addition to the current compensation received by Mr. Mooney under his employment agreement. Nicole Fernandez-McGovern, Chief Financial Officer Based on her agreement commencing with the date of appointment as CFO in August 2016, Ms. Fernandez-McGovern earned a salary of $66,000 per year, payable in monthly installments of $5,500 for 2017. In 2018, her monthly installment payment increased to $8,000 and effective upon the closing of the Merger, Ms. Fernandez-McGovern’s salary increased to $150,000. As part of her compensation upon the closing of the Merger, Ms. Fernandez-McGovern also received 10-year stock options to purchase 265,033 shares of Common Stock at an exercise price of $0.06 per share, of which half of the options vested upon issuance and the remainder will vest equally over two years. Additionally, on a quarterly basis, Ms. Fernandez-McGovern will be awarded 12,500 shares of stock options to purchase Common Stock at an exercise price per share equal to the market price of our Common Stock at the time of issuance during the term of her employment. Effective January 1, 2019, Ms. Fernandez-McGovern signed a new employment agreement with the Company, whereby her annual base salary increased to $180,000 and a ten-year grant of 50,000 stock options to purchase shares of Common Stock at an exercise price of $0.54 was awarded. In addition, Ms. Fernandez-McGovern will continue to receive quarterly grants of 12,000 stock options to purchase Common Stock at an exercise price equal to the market price of our Common Stock at the time of issue during the term of her employment. All of the awards will vest equally over two years. On September 30, 2019, the Board of Directors and the Compensation Committee approved a new compensatory arrangement for Ms. Fernandez-McGovern. On September 30, 2019, Ms. Fernandez-McGovern was awarded a stock option to purchase 25,000 shares of the Company’s Common Stock under the Company’s current shareholder approved equity incentive plan. The option will vest in equal amounts over a two-year term from the date of grant and will be exercisable for a period of five years from date of grant. The exercise price of the stock option is $0.31 per share, which was the fair market value of the Company’s common stock on the NYSE American on September 30, 2019. Ms. Fernandez-McGovern is also entitled to receive bonuses up to $39,000 in cash, 170,000 shares of restricted stock and 175,000 stock options upon the achievement of certain Company operational milestones. The foregoing compensation arrangements are in addition to the current compensation received by Ms. Fernandez-McGovern under her employment agreement.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Note 11 – Related Party Transactions The following reflects the related party transactions during the years ended December 31, 2019 and 2018. Promissory Notes The Company issued promissory notes for an aggregate amount of $76,050 (the “Related Party Notes A”) that accrued interest at an annual rate of 8% and were set to mature as of the date of the Merger. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $1,386 of interest expense, respectively. As of the Merger Date, the principal of $76,050 and the accrued interest of $7,239 were converted at $1.25 per share into 110,371 shares of the Company’s Common Stock. The Company issued promissory notes for an aggregate amount of $55,000 (the “Related Party Notes B”) that accrued interest at an annual rate of 8% and were set to mature as of the date of the Merger. It was determined that there were no aggregate beneficial conversion features. For the years ended December 31, 2019 and 2018, the Company recorded $0 and $1,002 of interest expense, respectively. As of the Merger Date, the principal of $55,000 and the accrued interest of $3,686 were converted at $1.25 per share into 77,769 shares of the Company’s Common Stock. Transactions with Officers The Company’s Chief Financial Officer, Nicole Fernandez-McGovern, is one of the principals of Premier Financial Filings, a full-service financial printer. Premier Financial Filings provided contracted financial services to the Company and their related expenses have been included within general and administrative expenses. For the years ended December 31, 2019 and 2018, Premier Financial Filings provided services to the Company resulting in fees of $7,753 and $13, 202, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note 12 – Income Taxes Prior to April 15, 2015, AgEagle Aerial Systems Inc. was treated as a disregarded entity for income tax purposes. Income taxes, if any, were the responsibility of the sole member. In April 2015, the Company was converted to a corporation. The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carryforwards. As of December 31, 2019 and 2018, the total of all deferred tax assets was $2,779,100 and $1,400,620 respectively. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the realization of the deferred tax assets the Company has established a valuation allowance of $2,779,100 and $1,400,620 for the years ended December 31, 2019 and 2018, respectively. The change in the valuation allowance for the years ended December 31, 2019 and 2018 was $1,378,480 and $501,548, respectively. On December 22, 2017, the Tax Cuts and Jobs Act (the “Act”) was signed into law. The Act decreases the U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% effective January 1, 2018. The Act also includes a number of other provisions including, among others, the elimination of net operating loss carrybacks and limitations on the use of future losses, the repeal of the Alternative Minimum Tax regime and the repeal of the domestic production activities deduction. These provisions are not expected to have a material effect on the Corporation. Given the significant complexity of the Act and anticipated additional implementation guidance from the Internal Revenue Service, further implications of the Act may be identified in future periods. At December 31, 2019, the Company had a net operating loss carry forward of approximately $9,300,681 with $2,043,670 expiring in 2035-2037 and approximately a $7,257,011 of net operating loss carry forward with no expiration. Management has determined that a 100% valuation allowance be established against net operating losses where it is more likely than not that such losses will expire or will not be available before they are utilized. The components of income tax benefit for the years ended December 31, 2019 and 2018 consist of the following: 2019 2018 Deferred tax benefit: Federal $ (1,198,182 ) $ (435,942 ) State (180,298 ) (65,606 ) Increase in valuation allowance $ (1,378,480 ) $ (501,548 ) A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company’s effective rate for the years ended December 31, 2019 and 2018 is as follows: 2019 2018 Amount Rate Amount Rate Computed tax at the expected statutory rate $ (1,182,446 ) 21.00 % $ (436,733 ) 21.00 % State and local income taxes, net of federal (177,832 ) 3.16 % (65,606 ) 3.16 % Other non-deductible expenses 653 (0.01 )% 743 (0.04 )% Other adjustments (18,856 ) 0.33 % 48 (0.00 )% Change in valuation allowance 1,378,480 (24.48 )% 501,548 (24.12 )% Income tax benefit $ — $ — The temporary differences, tax credits and carryforwards that gave rise to the following deferred tax assets at December 31, 2019 and 2018 is as follows: Deferred tax assets: 2019 2018 Deferred revenue $ 83,230 $ 1,182 Property and equipment 7,452 6,221 Interest 33,247 (5,826 ) Goodwill amortization (1,335 ) (17,876 ) Intangibles tax amortization 32,441 7,488 Stock options for consulting services employees and directors 85,019 32,083 Stock options for consulting services-related party 51,878 51,878 Common Stock for consulting services-related party 302,000 302,000 Merger Transaction Costs (64,071 ) — Warrant expense 2,194 2,194 Net operating loss carryforward 2,247,045 1,021,276 Total Deferred tax assets 2,779,100 1,400,620 Valuation allowance (2,779,100 ) (1,400,620 ) Net Deferred tax assets $ — $ —

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events Resignation of CEO and Chairman On March 12, 2020, the Company announced the appointment of CEO Barrett Mooney as Executive Chairman of the Board effective May 1, 2020, replacing AgEagle’s Founder, President and Current Chairman Bret Chilcott, who will remain with the Company as an advisor for 12 months until his planned retirement from AgEagle. Mooney will continue to serve as Chief Executive Officer until the date he assumes the Executive Chairman position, at which time he will resign as CEO. The Company has retained executive search firm Hobbs & Towne to assist with its search for a new CEO. Preferred C Share Conversions During the month of January 2020, Alpha Capital Anstalt converted 189 shares of Series C Preferred Stock into 350,000 shares of Common Stock at a conversion price of $0.54. In the beginning of April 2020, Alpha Capital Anstalt converted 250 shares of Series C Preferred Stock into 1,000,000 shares of Common Stock at a conversion price of $0.25. Securities Purchase Agreement On April 7, 2020, AgEagle Aerial Systems Inc.(the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with an institutional investor (the “Purchaser”). Pursuant to the terms of the Agreement, the Board of Directors of the Company (the “Board”) authorized 1,050 shares of a newly designated series of preferred stock, the Series E Convertible Preferred Stock (the “Preferred Stock”). The Preferred Stock is convertible at $0.25 per share into an aggregate of 4,200,000 shares of the Common Stock, par value $0.001 per share (the “Conversion Shares”). The purchase price for the Preferred Stock was $1,050,000 (the “Purchase Price”). The Company also entered into a Registration Rights Agreement, granting registration rights to the Purchaser with respect to the Conversion Shares and Common Stock underlying warrants currently owned by the Purchaser (the “Warrant Shares”). Registration Rights Pursuant to the terms of the Registration Rights Agreement, the Company shall file an initial registration statement registering the Conversion Shares and the Warrant Shares (the “Registrable Securities”), no later than the 15 th th th The Company shall pay to the Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the Purchase Price for failure to file the registration statement or have the registration statement declared effective by the dates set forth above. The parties agree that the maximum aggregate liquidated damages payable to the Purchaser shall be 6.0% of the Purchase Price paid by the Purchaser pursuant to the Agreement. If the Company fails to pay any partial liquidated damages in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Purchaser, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. Leak-Out Agreement On April 7, 2020, as a condition to the consummation of the Agreement, the Company entered into a Leak-Out Agreement with Mr. Bret Chilcott, a director and the President of the Company, and the Purchaser, with respect to the shares Mr. Chilcott beneficially owns. The restriction on the disposition of the shares is for a period of seven months from the date of the closing of the Agreement. Thereafter, for a period of an additional six months, Mr. Chilcott may sell no more than $25,000 per calendar month of shares of Company Common Stock. Amendment to the Articles of Incorporation On April 2, 2020, the Company’s Board authorized 1,050 shares of a newly designated series of preferred stock, the Series E Convertible Preferred Stock. The Series E Convertible Preferred Stock is convertible at $0.25 per share into an aggregate of 4,200,000 shares of the Common Stock. The Series E Convertible Preferred Stock has liquidation rights senior to the Common Stock, but pari passu with the Series C Preferred Stock and the Series D Preferred Stock. The Series E Convertible Preferred Stock has no voting rights. The conversion price adjusts for stock splits and combinations and is subject to anti-dilution protection for subsequent equity issuances until such time as no shares of Series E Preferred Stock is outstanding. The Certificate of Designation of the Series E Convertible Preferred Stock was filed with the State of Nevada on April 2, 2020.

Summary of Accounting Policies

Summary of Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation and Consolidation The consolidated financial statements include the accounts of AgEagle Aerial Systems Inc. and its wholly-owned subsidiaries AgEagle Aerial, Inc., EnerJex Kansas, Inc., Black Sable Energy, LLC, Black Raven Energy, Inc. Black Raven Energy, Inc. was dissolved effective November 2019. All significant intercompany balances and transactions have been eliminated in consolidation. The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements.
Use of estimates	Use of Estimates –
Fair Value of Financial Instruments	Fair Value of Financial Instruments –
Cash and Cash Equivalents	Cash and Cash Equivalents –
Receivables and Credit Policy	Receivables and Credit Polic – The Company estimates an allowance for doubtful accounts based upon an evaluation of the current status of receivables, historical experience, and other factors as necessary. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. The Company determined that no allowance was necessary as of December 31, 2019 and December 31, 2018.
Inventories	Inventorie –
Goodwill and Intangible Assets	Goodwill and Intangible Assets – Intangible assets from acquired businesses are recognized at fair value on the acquisition date and consist of customer programs, trademarks, customer relationships, technology and other intangible assets. Customer programs include values assigned to major programs of acquired businesses and represent the aggregate value associated with the customer relationships, contracts, technology and trademarks underlying the associated program and are amortized on a straight-line basis over a period of expected cash flows used to measure fair value, which ranges from four to five years.
Business Combinations	Business Combinations
Revenue Recognition and Concentration	Revenue Recognition and Concentration – Revenue from Contracts with Customers Under fixed-price contracts, the Company agrees to perform the specified work for a pre-determined price. To the extent the Company’s actual costs vary from the estimates upon which the price was negotiated, it will generate more or less profit or could incur a loss. The Company accounts for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company generally recognizes revenue on sales to customers, dealers and distributors upon satisfaction of performance obligations which generally occurs once controls transfer to customers, which is when product is shipped or delivered depending on specific shipping terms. As a result of the Agribotix acquisition, the Company now has an additional product line which is the sale of subscription services for use of the FarmLens Sales concentration information for customers comprising more than 10% of the Company’s total net sales such customers is summarized below: Percent of total sales for year ended December 31, Customers 2019 2018 Customer A 90.8 % 10.4 % Customer B * 18.0 % Accounts receivables due from Customer A comprised all of the accounts receivable as of December 31, 2019. The table below reflects our revenue for the periods indicated by product mix. For the Year Ended December 31, Type 2019 2018 Drone Assembly and Product Sales $ 267,622 $ 93,219 Subscription Sales 29,055 14,594 Total $ 296,677 $ 107,813
Vendor Concentration	Vendor Concentration – FarmLens
Shipping Costs	Shipping Costs –
Research and Development Expenses	Research and Development Expenses -
Earnings Per Share	Earnings Per Share –
Potentially Dilutive Securities	Potentially Dilutive Securities –
Income Taxes	Income Taxes – Accounting for Income Taxes
Stock-Based Compensation Awards	Stock-Based Compensation Awards – “Compensation – Stock Compensation”, The Black-Scholes option-pricing model requires the input of certain assumptions that require the Company’s judgment, including the expected term and the expected stock price volatility of the underlying stock. The assumptions used in calculating the fair value of stock-based compensation represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change resulting in the use of different assumptions, stock-based compensation expense could be materially different in the future.
Recently Issued Accounting Standards	Recently Issued Accounting Pronouncements – Adopted In January 2016, the FASB issued ASU 2016-01, Financial Instruments: Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, FASB issued Account Standards Update 2016-02 – Leases In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In January 2017, the FASB issued ASU 2017-01, Business Combinations—Clarifying the definition of a business In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other In May 2017, the FASB issued ASU 2017-09, Compensation—Stock Compensation Pending Adoption In August 2018, the FASB issued ASU 2018-13, Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement In August 2018, the FASB issued ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract Other recent accounting pronouncements issued by FASB did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

Summary of Accounting Policie_2

Summary of Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Sales concentration information	Sales concentration information for customers comprising more than 10% of the Company’s total net sales such customers is summarized below: Percent of total sales for year ended December 31, Customers 2019 2018 Customer A 90.8 % 10.4 % Customer B * 18.0 %
Revenue indicated by product mix	The table below reflects our revenue for the periods indicated by product mix. For the Year Ended December 31, Type 2019 2018 Drone Assembly and Product Sales $ 267,622 $ 93,219 Subscription Sales 29,055 14,594 Total $ 296,677 $ 107,813

Business Acquisition (Tables)

Business Acquisition (Tables)	12 Months Ended
	Dec. 31, 2019
Business Combinations [Abstract]
Schedule of fair values of the assets acquired and liabilities	The following table summarizes the total fair value of the consideration transferred as well as the fair values of the assets acquired and liabilities assumed. Common Stock consideration $ 3,000,000 Cash paid 1,000,000 Total purchase consideration 4,000,000 Inventory (3,685 ) Property and equipment (7,650 ) Intangibles assets (724,500 ) Contract liabilities 6,819 Goodwill $ 3,270,984
Proforma financial information	The following unaudited proforma financial information gives effect to the Company’s acquisition of Agribotix as if the acquisition had occurred on January 1, 2018 and had been included in the Company’s consolidated statement of operations for the year ended December 31, 2018: For the year ended December 31, 2018 Revenue $ 314,486 Net Loss $ (2,702,928 )

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventories	Inventories consist of the following at: December 31, 2019 2018 Raw materials $ 193,022 $ 109,826 Work-in process 26,456 30,088 Finished goods 11,689 19,937 Gross inventory 231,167 159,851 Less obsolecense reserve (10,000 ) (10,369 ) Total $ 221,167 $ 149,482

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consist of the following at: December 31, 2019 2018 Property and equipment $ 140,758 $ 116,313 Less accumulated depreciation (102,982 ) (87,939 ) $ 37,776 $ 28,374

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Goodwill and intangible assets were comprised of the following as of December 31, 2019: Estimated Life Balance at January 1, 2019 Accumulated Amortization Impairment Balance at December 31, 2019 Intellectual Property/Technology 5 Years $ 433,400 $ (115,574 ) $ — $ 317,826 Customer Base 5 Years 72,000 (19,200 ) — 52,800 Tradenames and Trademarks 5 Years 58,200 (15,520 ) — 42,680 Non-compete Agreement 4 Years 160,900 (53,633 ) — 107,267 Total intangible assets 724,500 (203,927 ) — $ 520,573 Goodwill 3,270,984 — (162,984 ) 3,108,000 Total $ 3,995,484 $ $ (162,984 ) $ 3,628,573
Future amortization	Future amortization is as follows for fiscal years ending: 2020 2021 2022 2023 Intellectual Property/Technology $ 86,680 $ 86,680 $ 86,680 $ 57,786 Customer Base 14,400 14,400 14,400 9,600 Tradenames and Trademarks 11,640 11,640 11,640 7,760 Non-compete Agreement 40,225 40,225 26,817 — Total $ 152,945 $ 152,945 $ 139,537 $ 75,146

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The significant assumptions relating to the valuation of the Company’s stock options granted during the years ended December 31, 2019 were as follows: December 31, 2019 Dividend yield 1.62% Expected life 3.0-6.1 Years Expected volatility 82.38-88.62% Risk-free interest rate 1.56-2.23% The significant assumptions relating to the valuation of the Company’s stock options granted during the year ended December 31, 2018 were as follows: December 31, 2018 Dividend yield 0% Expected life 3.5-7.0 Years Expected volatility 76.04% to 80.5% Risk-free interest rate 2.59% to 3.01
Summary of Stock Options	A summary of the options activity for the year ended December 31, 2019 is as follows: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2019 1,494,158 $ 0.46 6.93 years $ 417 ,504 Granted 1,131,000 0.37 6.27 years — Exercised/Forfeited (144,688 ) 0.99 —years — Outstanding at December 31, 2019 2,480,470 0.39 6.28 years 378,111 Exercisable at period end 1,521,859 $ 0.36 6.10 years $ 301 ,051 A summary of the options activity for the years ended December 31, 2018 is as follows: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2018 1,134,830 $ 0.06 8.5 years $ — Granted 534,598 1.35 5.94 years $ — Cancelled (175,270 ) 0.60 —years $ — Outstanding at December 31, 2018 1,494,158 $ 0.46 6.93 years $ 417,504 Exercisable at end of the year 782,147 $ 0.22 7.07 years $ 356,979

Warrants to Purchase Common S_2

Warrants to Purchase Common Stock (Tables)	12 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Summary of activity related to warrants	A summary of activity related to warrants for the year ended December 31, 2019 follows: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Outstanding at January 1, 2019 4,531,924 $ 0.72 5.05 Outstanding at December 31, 2019 4,531,924 $ 0.72 5.05 Exercisable at December 31, 2019 4,531,924 $ 0.72 4.05 A summary of activity related to warrants for the twelve months ended December 31, 2018 follows: Shares Weighted- Average Exercise Price ($) Weighted-Average Remaining Contractual Term Outstanding at January 1, 2017 828,221 $ 1.51 5.34 Granted 3,703,703 $ 0.54 4.99 Outstanding at December 31, 2018 4,531,924 $ 0.72 5.05 Exercisable at December 31, 2018 4,531,924 $ 0.72 5.05

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The components of income tax benefit for the years ended December 31, 2019 and 2018 consist of the following: 2019 2018 Deferred tax benefit: Federal $ (1,198,182 ) $ (435,942 ) State (180,298 ) (65,606 ) Increase in valuation allowance $ (1,378,480 ) $ (501,548 )
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company’s effective rate for the years ended December 31, 2019 and 2018 is as follows: 2019 2018 Amount Rate Amount Rate Computed tax at the expected statutory rate $ (1,182,446 ) 21.00 % $ (436,733 ) 21.00 % State and local income taxes, net of federal (177,832 ) 3.16 % (65,606 ) 3.16 % Other non-deductible expenses 653 (0.01 )% 743 (0.04 )% Other adjustments (18,856 ) 0.33 % 48 (0.00 )% Change in valuation allowance 1,378,480 (24.48 )% 501,548 (24.12 )% Income tax benefit $ — $ —
Schedule of Deferred Tax Assets and Liabilities	The temporary differences, tax credits and carryforwards that gave rise to the following deferred tax assets at December 31, 2019 and 2018 is as follows: Deferred tax assets: 2019 2018 Deferred revenue $ 83,230 $ 1,182 Property and equipment 7,452 6,221 Interest 33,247 (5,826 ) Goodwill amortization (1,335 ) (17,876 ) Intangibles tax amortization 32,441 7,488 Stock options for consulting services employees and directors 85,019 32,083 Stock options for consulting services-related party 51,878 51,878 Common Stock for consulting services-related party 302,000 302,000 Merger Transaction Costs (64,071 ) — Warrant expense 2,194 2,194 Net operating loss carryforward 2,247,045 1,021,276 Total Deferred tax assets 2,779,100 1,400,620 Valuation allowance (2,779,100 ) (1,400,620 ) Net Deferred tax assets $ — $ —

Summary of Accounting Policie_3

Summary of Accounting Policies (Details) - Sales Revenue, Net [Member]	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Customer A
Concentration percentage	90.80%	10.40%
Customer B
Concentration percentage		18.00%

Summary of Accounting Policie_4

Summary of Accounting Policies (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues	$ 296,677	$ 107,813
Product [Member]
Revenues	267,622	93,219
Subscription [Member]
Revenues	$ 29,055	$ 14,594

Summary of Accounting Policie_5

Summary of Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary Of Accounting Policies [Line Items]
Cash equivalents	$ 0	$ 0
FDIC limit	250,000
Allowance for doubtful accounts receivable	0	0
Estimated obsolescence and shrinkage of inventory	10,000	10,369
Shipping Costs	5,493	5,239
Research and Development Expenses	$ 38,948	$ 0
Warrant [Member]
Summary Of Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,531,924	4,531,924
Option [Member]
Summary Of Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,480,470	1,494,153
Series C Preferred Stock [Member]
Summary Of Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,501	4,662
Common Stock [Member]
Summary Of Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,483,333
Convertible notes [Member]
Summary Of Accounting Policies [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		8,633,333

Business Acquisition (Details)

Business Acquisition (Details) - USD ($)	1 Months Ended
	Jul. 25, 2018	Dec. 31, 2019	Dec. 31, 2018
Goodwill		$ 3,108,000	$ 3,270,984
Agribotix [Member]
Common stock consideration	$ 3,000,000
Cash paid	1,000,000
Total purchase consideration	4,000,000
Inventory	(3,685)
Property and equipment	(7,650)
Intangibles	(724,500)
Contract liabilities	6,819
Goodwill	$ 3,270,984

Business Acquisition (Details 1

Business Acquisition (Details 1)	12 Months Ended
	Dec. 31, 2018USD ($)
Business Combinations [Abstract]
Revenue	$ 314,486
Net Income	$ (2,702,928)

Business Acquisition (Details N

Business Acquisition (Details Narrative) - Seller [Member]	1 Months Ended
	Nov. 20, 2017USD ($)$ / sharesshares
Cash payment | $	$ 150,000
Common stock issued | shares	200,000
Share Price | $ / shares	$ 5

Inventories (Details)

Inventories (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 193,022	$ 109,826
Work-in-process	26,456	30,088
Finished goods	11,689	19,937
Gross Inventory	231,167	159,851
Less obsolete reserve	(10,000)	(10,369)
Total inventory	$ 221,167	$ 149,482

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Property and equipment	$ 140,758	$ 116,313
Less accumulated depreciation	(102,982)	(87,939)
Property and equipment, net	$ 37,776	$ 28,374

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 15,043	$ 17,980

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2019USD ($)
Gross Cost	$ 3,995,484
Impairment	(162,984)
Net Book Value	$ 3,628,573
Intellectual Property/Technology [Member]
Estimated Life	5 years
Gross Cost	$ 433,400
Accumulated Amortization	(115,574)
Impairment	0
Net Book Value	$ 317,826
Customer Base [Member]
Estimated Life	5 years
Gross Cost	$ 72,000
Accumulated Amortization	(19,200)
Impairment	0
Net Book Value	$ 52,800
Trademarks and Trade Names [Member]
Estimated Life	5 years
Gross Cost	$ 58,200
Accumulated Amortization	(15,520)
Net Book Value	$ 42,680
Non-compete agreement [Member]
Estimated Life	4 years
Gross Cost	$ 160,900
Accumulated Amortization	(53,633)
Impairment	0
Net Book Value	107,267
Intangible Assets [Member]
Gross Cost	724,500
Accumulated Amortization	(203,927)
Impairment	0
Net Book Value	520,573
Goodwill [Member]
Gross Cost	3,270,984
Impairment	(162,984)
Net Book Value	$ 3,108,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details 1)	Dec. 31, 2019USD ($)
2020	$ 152,945
2021	152,945
2022	139,537
2023	75,146
Intellectual Property/Technology [Member]
2020	86,680
2021	86,680
2022	86,680
2023	57,786
Customer Base [Member]
2020	14,400
2021	14,400
2022	14,400
2023	9,600
Trademarks and Trade Names [Member]
2020	11,640
2021	11,640
2022	11,640
2023	7,760
Non-compete agreement [Member]
2020	40,225
2021	40,225
2022	26,817
2023

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 156,545	$ 47,382
Weighted average remaining amortization period	3 years 6 months
Goodwill impairment charge	$ 162,984

Debt (Details Narrative)

Debt (Details Narrative) - USD ($)

Feb. 03, 2017

Sep. 06, 2016

May 06, 2015

Mar. 26, 2018

Sep. 30, 2017

Jul. 31, 2017

Dec. 31, 2019

Dec. 31, 2018

May 06, 2016

Oct. 31, 2017

Sep. 24, 2017

Sep. 15, 2017

May 15, 2017

Mar. 05, 2017

Jan. 24, 2017

Dec. 15, 2016

Debt Instrument [Line Items]

Exercise price

$ 1.51

Promissory notes

$ 0

$ 40,998

EnerJex

Debt Instrument [Line Items]

Interest expenses

$ 501

Common stock

787,891

Principal payments

$ 40,998

Series C Convertible Preferred Stock [Member]

Debt Instrument [Line Items]

Preffered shares

1,631

Related Party Notes A

Debt Instrument [Line Items]

Share price

$ 2

$ 2

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

8.00%

Interest expenses

$ 0

1,386

Number of shares con version

77,769

Promissory notes

$ 16,050

$ 30,000

$ 30,000

Related Party Notes B

Debt Instrument [Line Items]

Share price

$ 2

$ 2

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

8.00%

8.00%

Interest expenses

0

1,002

Promissory notes

$ 32,000

$ 10,000

$ 10,000

Principal | EnerJex

Debt Instrument [Line Items]

Conversion of debt amount

$ 125,556

Principal | Related Party Notes A

Debt Instrument [Line Items]

Conversion of debt amount

76,050

Principal | Related Party Notes B

Debt Instrument [Line Items]

Conversion of debt amount

55,000

Accrued Interest | EnerJex

Debt Instrument [Line Items]

Conversion of debt amount

4,171

Accrued Interest | Related Party Notes A

Debt Instrument [Line Items]

Conversion of debt amount

7,239

Accrued Interest | Related Party Notes B

Debt Instrument [Line Items]

Conversion of debt amount

$ 3,686

2015 Holders

Debt Instrument [Line Items]

Convertible Notes Payable

$ 500,000

Share price

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Maturity date

Nov. 6, 2016

Interest expenses

0

9,111

Number of shares con version

814,381

Conversion price

$ 1.25

2015 Holders | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 500,000

2015 Holders | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 114,556

2016 Holders

Debt Instrument [Line Items]

Convertible Notes Payable

$ 300,000

Share price

$ 3

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Maturity date

Sep. 30, 2017

Interest expenses

0

5,467

Number of shares con version

454,440

Conversion price

$ 1.25

2016 Holders | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 300,000

2016 Holders | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 42,933

2017 Holder Note A

Debt Instrument [Line Items]

Convertible Notes Payable

$ 175,000

Original issue discount

$ 25,000

25,000

Share price

$ 2.50

Debt Instrument, Interest Rate, Stated Percentage

18.00%

Interest expenses

0

7,077

Number of shares con version

139,567

Conversion price

$ 1.25

Proceeds from convetible debt

$ 101,250

Warrants purchase

200,000

Exercise price

$ 2.50

2017 Holder Note A | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 175,000

2017 Holder Note A | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 35,642

2017 Holder Note A

Debt Instrument [Line Items]

Warrants purchase

300,000

2017 Note B

Debt Instrument [Line Items]

Convertible Notes Payable

$ 100,005

Share price

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Maturity date

Feb. 28, 2018

Interest expenses

0

1,822

Number of shares con version

48,194

Conversion price

$ 1.25

2017 Note B | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 100,005

2017 Note B | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 5,600

2017 Note C

Debt Instrument [Line Items]

Convertible Notes Payable

$ 35,000

Share price

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Maturity date

Feb. 28, 2018

Interest expenses

0

638

Number of shares con version

68,540

Conversion price

$ 1.25

2017 Note C | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 35,000

2017 Note C | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 1,369

2017 Note D

Debt Instrument [Line Items]

Convertible Notes Payable

$ 50,000

Share price

$ 2

Debt Instrument, Interest Rate, Stated Percentage

8.00%

Interest expenses

$ 0

$ 911

Number of shares con version

110,371

Conversion price

$ 1.25

2017 Note D | Principal

Debt Instrument [Line Items]

Conversion of debt amount

$ 50,000

2017 Note D | Accrued Interest

Debt Instrument [Line Items]

Conversion of debt amount

$ 1,722

Related Party Notes A

Debt Instrument [Line Items]

Conversion price

$ 1.25

Equity (Details)

Equity (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Dividend yield	1.62%	0.00%
Minimum [Member]
Expected life	3 years	3 years 6 months
Expected volatility	82.38%	76.04%
Risk-free interest rate	1.56%	2.59%
Maximum [Member]
Expected life	6 years 1 month 6 days	7 months
Expected volatility	88.62%	80.50%
Risk-free interest rate	2.23%	3.01%

Equity (Details 1)

Equity (Details 1) - USD ($)	Oct. 04, 2017	May 01, 2015	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Options
Options Outstanding, Beginning Balance			1,494,158	1,134,830
Options Granted			1,131,000	534,598
Options cancelled			(144,688)	(175,270)
Options Outstanding, Ending Balance			2,480,470	1,494,158	1,134,830
Options Exercisable at end			1,521,859	782,147
Weighted Avg. Exercise Price
Weighted Avg. Exercise Price Outstanding, Beginning Balance			$ 0.46	$ 0.06
Weighted Avg. Exercise Price Granted	$ 0.06	$ 2.60	0.37	1.35
Weighted Avg. Exercise Price cancelled			0.99	0.6
Weighted Avg. Exercise Price Outstanding, Ending balance			0.39	0.46	$ 0.06
Weighted Avg. Exercise Price Exercisable at end			$ 0.36	$ 0.22
Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term Outstanding			6 years 3 months 11 days	6 years 11 months 4 days	8 years 6 months
Weighted Average Remaining Contractual Term Granted		5 years	6 years 3 months 8 days	5 years 11 months 8 days
Weighted Average Remaining Contractual Term Exercisable at end			6 years 1 month 6 days	7 years 26 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value Outstanding, Beginning Balance			$ 417,504	$ 0
Aggregate Intrinsic Value Granted			0	0
Aggregate Intrinsic Value Cancelled			0	0
Aggregate Intrinsic Value Outstanding, at end			378,111	417,504	$ 0
Aggregate Intrinsic Value Exercisable at end			$ 301,051	$ 356,979

Equity (Details Narrative)

Equity (Details Narrative) - USD ($)	May 03, 2019	May 11, 2018	Oct. 04, 2017	May 01, 2015	Jun. 18, 2019	Apr. 30, 2018	Apr. 16, 2018	Nov. 21, 2017	Dec. 31, 2019	Dec. 31, 2018
Investor relations expense									$ 400,415
Option available under plan									3,000,000
Cash compensation									$ 500,000
Option to purchase stock				$ 207,055
Option granted									1,131,000	534,598
Term				5 years					6 years 3 months 8 days	5 years 11 months 8 days
Exercise price			$ 0.06	$ 2.60					$ 0.37	$ 1.35
Modification of options to purchase common stock			207,055
Stock-based compensation expense									$ 259,194
Employees and directors one [Member]
Option to purchase stock									1,131,000
Fair-value of options									269,700
Stock-based compensation expense									58,491
Employees and directors one [Member] | Minimum [Member]
Exercise price										$ 0.29
Expiration date										Dec. 31, 2023
Employees and directors one [Member] | Maximum [Member]
Exercise price										$ 0.54
Expiration date										Mar. 28, 2029
Employees and directors [Member]
Option to purchase stock										$ 534,598
Fair-value of options										387,052
Stock-based compensation expense									$ 196,485	102,698
Employees and directors [Member] | Minimum [Member]
Exercise price									$ 0.51
Expiration date									Mar. 30, 2023
Employees and directors [Member] | Maximum [Member]
Exercise price									$ 4.33
Expiration date									Dec. 15, 2028
Employees and directors [Member]
Option to purchase stock			$ 927,775
Exercise price			$ 0.06
Stock-based compensation expense									$ 5,335	$ 7,895
Consulting Agreement [Member]
Common stock issued					$ 500,000
Investor relations expense					$ 170,000
Fair value					$ 0.34
Option to purchase stock	$ 207,055
Expiration date	Jan. 14, 2021
Investor Relations Agreement [Member]
Common stock issued					$ 50,000
Investor relations expense					$ 20,500
Fair value					$ 0.41
AgEagle | Series C Convertible Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)									1,471,425
Preferred stock converted (shares)									1,624
Additional Common stock issued upon conversion of preferred stock (shares)									3,020,797
Additional Preferred stock converted (shares)									4,000
Financing cost									$ 4,000,000
AgEagle | Series A Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)									902,186
Alpha Capital Anstalt [Member] | Series C Convertible Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)						2,879		408,552	2,150,000	1,611,082
Preferred stock converted (shares)									1,161	2,467
Common stock issued upon conversion of preferred stock (shares)		$ 250,000						$ 2,612,245
Additional Common stock issued upon conversion of preferred stock (shares)		163,265
Additional Preferred stock converted (shares)		250
Alpha Capital Anstalt [Member] | Series B Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)							5,388
Preferred stock converted (shares)							8.25

Warrants to Purchase Common S_3

Warrants to Purchase Common Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Warrants
Warrants Outstanding, Beginning Balance	4,531,924	828,221
Warrants Granted		3,703,703
Warrants Outstanding, Ending Balance	4,531,924	4,531,924	828,221
Warrants Exercisable at end	4,531,924	4,531,924
Weighted Avg. Exercise Price
Weighted Avg. Exercise Price Outstanding, Beginning Balance	$ 0.72	$ 1.51
Warrants Granted		0.54
Weighted Avg. Exercise Price Outstanding, Ending balance	0.72	0.72	$ 1.51
Weighted Avg. Exercise Price Exercisable at end	$ 0.72	$ 0.72
Weighted-Average Remaining Contractual Term
Weighted-Average Remaining Contractual Term Outstanding	5 years 18 days	5 years 18 days	5 years 4 months 2 days
Weighted-Average Remaining Contractual Term Granted		4 years 11 months 26 days
Weighted-Average Remaining Contractual Term Exercisable at end	4 years 18 days	5 years 18 days

Warrants to Purchase Common S_4

Warrants to Purchase Common Stock (Details Narrative)	12 Months Ended
	Dec. 31, 2019USD ($)$ / sharesshares
Notes to Financial Statements
Number of warrants purchased | shares	828,221
Exercise price | $ / shares	$ 1.51
Warrants exercisable | shares	3,703,703
Proceeds from warrants | $	$ 2,000,000
Warrant term	5 years
Warrant Exercise price | $ / shares	$ 0.54

Commitments & Contingencies (De

Commitments & Contingencies (Details Narrative) - USD ($)

May 03, 2019

Jul. 09, 2018

Aug. 09, 2016

May 01, 2015

Sep. 30, 2019

Jan. 31, 2019

Dec. 18, 2018

Nov. 27, 2018

Oct. 31, 2018

Mar. 31, 2019

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Aug. 31, 2016

Commitments and Contingencies Disclosure [Line Items]

Operating Leases, Rent Expense

$ 30,000

$ 13,600

Periodic payment

$ 500

Lease termination date

Sep. 30, 2019

Option outstanding

2,480,470

1,494,158

1,134,830

Common stock to be held in escrow , Shares

1,215,278

Common stock to be held in escrow, Value

$ 350,000

Stock option granted

1,131,000

534,598

Exercise price

$ 1.51

Common stock, shares issued

15,424,394

12,549,394

Commitments description

Effective December 18, 2018, an amendment was signed for the original employment offer letter dated July 9, 2018, thereby providing an amendment to provide that in lieu of the issuance of 75,000 shares of restricted Common Stock of the Company (the “Shares”), the Company shall award to Mr. Mooney 125,000 Non-qualified Stock Options (the “Stock Options”) under the Company’s 2017 Omnibus Equity Incentive Plan (the “Equity Plan”). The Stock Options shall be subject to the terms of the Equity Plan and standard option award agreement which shall have a term of 10 years and provide for vesting over a one-year period and exercisability at an exercise price equal to the fair market value of the Company’s Common Stock as of the date of the grant. The award of 75,000 shares were returned to the Company and immediately cancelled.

Option to purchase stock

$ 207,055

Investor relations agreement [Member]

Commitments and Contingencies Disclosure [Line Items]

Common stock, shares issued

125,000

Consulting Agreement [Member]

Commitments and Contingencies Disclosure [Line Items]

Common stock percentage

5.86%

Option Exercise price

$ 0.06

Option to purchase stock

$ 207,055

Expiration date

Jan. 14, 2021

AgEagle

Commitments and Contingencies Disclosure [Line Items]

Capital stock oustanding

5,439,526

Common stock conversion

7,944,941

Option outstanding

685,100

Warrants to purchase in connection with common stock

500,000

Conversion of option

1,134,830

Warrants to purchase shares of common stock

828,221

AgEagle | Series A Preferred Stock [Member]

Commitments and Contingencies Disclosure [Line Items]

Common stock issued upon conversion of preferred stock (shares)

902,186

Deferred salaries and fees

$ 297,500

Common stock issued in connection with payment to deferred salaries and fees

1,032,986

GreenBlock Capitalt [Member] | Consulting Agreement [Member]

Commitments and Contingencies Disclosure [Line Items]

Consulting, Description

Consultant shall receive (i) $25,000 per month during the term of the agreement, (ii) 500,000 shares of restricted Common Stock upon execution of the agreement, and (iii) up to 2,500,000 shares of restricted Common Stock upon the achievement of predetermined milestones.

Louisa Ingargiola [Member]

Commitments and Contingencies Disclosure [Line Items]

Stock option granted

41,250

Exercise price

$ 0.77

Additionally quarterly grant received

$ 16,500

Chief Financial Officer [Member] | Fernandez-McGovern [Member]

Commitments and Contingencies Disclosure [Line Items]

Stock option granted

50,000

Exercise price

$ 0.54

Additionally quarterly grant received

$ 12,000

Base salary

$ 180,000

Bonus in cash

$ 39,000

Number of restricted stock issued

170,000

Number of stock options

175,000

Chief Executive Officer [Member] | Barrett Mooney [Member]

Commitments and Contingencies Disclosure [Line Items]

Stock option granted

75,000

12,500

Exercise price

$ 3.55

Base salary

$ 220,000

$ 66,000

Restricted common stock issued

75,000

Bonus in cash

$ 48,000

Number of restricted stock issued

250,000

Number of stock options

225,000

Chief Executive Officer [Member] | Barrett Mooney [Member] | 2017 Omnibus Equity Incentive Plan [Member]

Commitments and Contingencies Disclosure [Line Items]

Nonqualified stock options

30,000

20,000

55,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 26, 2018	Dec. 31, 2019	Dec. 31, 2018	Sep. 24, 2017	Sep. 15, 2017	May 15, 2017	Mar. 05, 2017	Jan. 24, 2017	Dec. 15, 2016
Promissory notes		$ 0	$ 40,998
General and administrative expenses		1,850,225	1,333,371
Related Party Notes A
Promissory notes				$ 16,050				$ 30,000	$ 30,000
Number of shares con version	77,769
Related Party Notes A | Principal
Conversion of debt amount	$ 76,050
Related Party Notes A | Accrued Interest
Conversion of debt amount	7,239
Related Party Notes B
Promissory notes					$ 32,000	$ 10,000	$ 10,000
Related Party Notes B | Principal
Conversion of debt amount	55,000
Related Party Notes B | Accrued Interest
Conversion of debt amount	$ 3,686
Nicole Fernandez-McGovern | Premier Financial Filings | Chief Financial Officer
General and administrative expenses		7,753	13,202
Consulting Agreement | Related Party Notes A
Promissory notes		$ 76,050
Accrued interest rate		8.00%
Interest expense		$ 0	1,386
Number of shares con version		110,371
Conversion price		$ 1.25
Consulting Agreement | Related Party Notes A | Principal
Conversion of debt amount		$ 76,050
Consulting Agreement | Related Party Notes A | Accrued Interest
Conversion of debt amount		7,239
Consulting Agreement | Related Party Notes B
Promissory notes		$ 55,000
Accrued interest rate		8.00%
Interest expense		$ 0	$ 1,002
Number of shares con version		77,769
Conversion price		$ 1.25
Consulting Agreement | Related Party Notes B | Principal
Conversion of debt amount		$ 55,000
Consulting Agreement | Related Party Notes B | Accrued Interest
Conversion of debt amount		$ 3,686

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Deferred tax benefit:
Federal	$ (1,198,182)	$ (435,942)
State	(180,298)	(65,606)
Increase in valuation allowance	$ (1,378,480)	$ (501,548)

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Computed tax at the expected statutory rate	$ (1,182,446)	$ (436,733)
State and local income taxes, net of federal	(177,832)	(65,606)
Other non-deductible expenses	653	743
Other adjustments	(18,856)	48
Change in valuation allowance	1,378,480	501,548
Income tax benefit	$ 0	$ 0
Computed tax at the expected statutory rate	21.00%	21.00%
State and local income taxes, net of federal	3.16%	3.16%
Other non-deductible expenses	(0.01%)	(0.04%)
Other adjustments	0.33%	(0.00%)
Change in valuation allowance	(24.48%)	(24.12%)
Income tax benefit	0.00%	0.00%

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Deferred revenue	$ 83,230	$ 1,182
Property and equipment	7,452	6,221
Interest	33,247	(5,826)
Goodwill amortization	(1,335)	(17,876)
Intangibles tax amortization	32,441	7,488
Stock options for consulting services employees and directors	85,019	32,083
Stock options for consulting services-related party	51,878	51,878
Common Stock for consulting services-related party	302,000	302,000
Merger Transaction Costs	(64,071)	0
Warrant expense	2,194	2,194
Net operating loss carryforward	2,247,045	1,021,276
Total Deferred tax assets	2,779,100	1,400,620
Valuation allowance	(2,779,100)	(1,400,620)
Net Deferred tax assets	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Total Deferred tax assets	$ 2,779,100	$ 1,400,620
Valuation allowance	(2,779,100)	(1,400,620)
Increase in valuation allowance	(1,378,480)	$ (501,548)
Operating loss carry forward	$ 9,300,681
Minimum [Member]
Expiration period	Jan. 1, 2035
Maximum [Member]
Expiration period	Dec. 31, 2037

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 07, 2020	Apr. 02, 2020	Apr. 01, 2020	Jan. 31, 2020	Apr. 30, 2018	Nov. 21, 2017	Dec. 31, 2019	Dec. 31, 2018
Preferred stock, shares authorized							25,000,000	25,000,000
Common stock, par value							$ 0.001	$ 0.001
Series C Convertible Preferred Stock [Member]
Preferred stock, shares authorized							10,000	10,000
Alpha Capital Anstalt [Member] | Series C Convertible Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)					2,879	408,552	2,150,000	1,611,082
Preferred stock converted (shares)							1,161	2,467
Subsequent Event [Member] | Series E Convertible Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)		4,200,000
Preferred stock, shares authorized		1,050
Conversion Price		$ 0.25
Subsequent Event [Member] | Series E Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]
Common stock issued upon conversion of preferred stock (shares)	4,200,000
Preferred stock, shares authorized	1,050
Conversion Price	$ 0.25
Common stock, par value	$ 0.001
Purchase Price	$ 1,050,000
Subsequent Event [Member] | Alpha Capital Anstalt [Member] | Series C Convertible Preferred Stock [Member]
Common stock issued upon conversion of preferred stock (shares)			1,000,000	350,000
Preferred stock converted (shares)			250	189